Peer-Reviewed Publications

Aspergillosis

• Garcia RS, et al. Sensitivity and specificity of a blood and urine galactomannan antigen assay for diagnosis of systemic aspergillosis in dogs. J VET INTERN MED 2012;26:911-919.
• Schultz RM, et al. Clinicopathologic and diagnostic imaging characteristics of systemic aspergillosis in 30 dogs. J VET INTERN MED 2008;22:851-859.
• Taylor AR, et al. Clinical features and magnetic resonance imaging findings in 7 dogs with central nervous system aspergillosis. J VET INTERN MED 2015;29:1556-1563.
• Corrigan VK, et al. Treatment of disseminated aspergillosis with posaconazole in 10 dogs. J VET INTERN MED 2016;30:167-173.
• Billen F, et al. Comparison of the value of measurement of serum galactomannan and Aspergillus-specific antibodies in the diagnosis of canine sino-nasal aspergillosis. VET MICRO 2009;133:358-365.
• Pomrantz JS, et al. Comparison of serologic evaluation via agar gel immunodiffusion and fungal culture of tissue for the diagnosis of nasal aspergillosis in dogs. J AM VET MED ASSOC. 2007;230:1319-1323.
• Barrs VR, et al. Sinonasal and sino-orbital aspergillosis in 23 cats: Aetiology, clinicopathological features and treatment outcomes. VET J 2012;191:58-64.
• Whitney J, et al. Evaluation of serum galactomannan detection for diagnosis of feline upper respiratory tract aspergillosis. VET MICRO 2013;162:180-185.

Blastomycosis:

• Motschenbacher LO, et al. Retrospective analysis of the effects of Blastomyces antigen concentration in urine and radiographic findings on survival in dogs with blastomycosis. J VET INTERN MED 2019.
• Spector D, et al. Antigen and antibody testing for the diagnosis of blastomycosis in dogs. J VET INTERN MED 2008;22:839-843.
• Mourning AC, et al. Evaluation of an enzyme immunoassay for antibodies to a recombinant Blastomyces adhesin-1 repeat antigen as an aid in the diagnosis of blastomycosis in dogs. J AM VET MED ASSOC 2015;247:1133-1138. 
• Foy DS, et al. Serum and urine Blastomyces antigen concentrations as markers of clinical remission in dogs treated for systemic blastomycosis. J VET INT MED 2014;28:305-310.
• Legendre AM, et al. Treatment of blastomycosis with itraconazole in 112 dogs. J VET INTERN MED 1996;10:365-371.
• Mazepa ASW, et al. Retrospective comparison of the efficacy of fluconazole or itraconazole for the treatment of systemic blastomycosis in dogs. J VET INTERN MED 2011;25:440-445.
  
• Gilor C, et al. Clinical aspects of natural infection with Blastomyces dermatitidis in cats: 8 cases (1991-2005). J AM VET MED ASSOC 2006;229:96-99.
• Crews LJ, et al. Radiographic findings in dogs with pulmonary blastomycosis: 125 cases (1989-2006). J AM VET MED ASSOC 2008;232:215-221.

Coccidioidomycosis:

• Holbrook ED, et al. Novel canine anti-Coccidioides immunoglobulin G enzyme immunoassay aids in diagnosis of coccidioidomycosis in dogs. MED MYCOL 2019;57:800-806.
• Kirsch EJ, et al. Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis. CLIN VACC IMMUNOL 2012;19:343-345.
• Gunstra A, et al. Sensitivity of serologic testing in dogs diagnosed with coccidioidomycosis in histology: 52 cases (2012-2013). J AM ANIM HOSP ASSOC 2019;55:238-242.
• Johnson LR, et al. Clinical, clinicopathologic, and radiographic findings in dogs with coccidioidomycosis: 24 cases (1995-2000). J AM VET MED ASSOC 2003;222:461-466.
• Arbona N, et al. Clinical features of cats diagnosed with coccidioidomycosis in Arizona, 2004-2018. J FEL MED SURG 2020;22:129-137.
• Shubitz LF, et al. Incidence of Coccidioides infection amoung dogs residing in a region in which the organism is endemic. J AM VET MED ASSOC 2005;226:1846-1850.
• Crabtree AC, et al. Relationship between radiographic hilar lymphadenopathy and serologic titers for Coccidioides sp. In dogs in an endemic region. VET RADIOL ULTRASOUND 2008;49:501-503.
• Chow NA, et al. Development of an enzyme immunoassay for detection of antibodies against Coccidioides in dogs and other mammalian species. PLOS ONE 2017;12:e0175081.

Cryptococcosis:

• Trivedi SR, et al. Clinical features and epidemiology of cryptococcosis in cats and dogs in California: 93 cases (1988-2010). J AM VET MED ASSOC 2011;239:357-369.
• Jacobs GJ, et al. Cryptococcal infection in cats: factors influencing treatment outcome, and results of sequential serum antigen titers in 35 cats. J VET INTERN MED 1997;11:1-4.
• Duncan CG, et al. Evaluation of risk factors for Cryptococcus gattii infection in dogs and cats. J AM VET MED ASSOC 2006;228:377-382.
• Malik R, e al. A latex cryptococcal antigen agglutination test for diagnosis and monitoring of therapy for cryptococcosis. AUST VET J 1996;74:358-364.
• O’Brien CR, et al. Long-term outcome of therapy for 59 cats and 11 dogs with cryptococcosis. AUST VET J 2006;84:384-392.
• Sykes JE, et al. Clinical signs, imaging features, neuropathology, and outcome in cats and dogs with central nervous system cryptococcosis from California. J VET INTERN MED 2010;24:1427-1438.

Histoplasmosis:

• Grinstead, et al. Invasive fungal rhinitis with adnexal involvement caused by Histoplasma capsulatum in a cat from a non-enzootic location. J FEL MED SURG 2021, Feb 15;7(1).
• Cook AK, et al. Clinical evaluation of urine Histoplasma capsulatum antigen measurement in cats with suspected disseminated histoplasmosis. J FEL MED SURG 2012;14:512-515.
• Cunningham L, et al. Sensitivity and specificity of Histoplasma antigen detection by enzyme immunoassay. J AM ANIM HOSP ASSOC 2015;51:306-310.
• Hanzlicek AS, et al. Antigen concentrations as an indicator of clinical remission and disease relapse in cats with histoplasmosis. J VET INTERN MED 2016;30:1065-1073.
• Rothenburg L, et al. A monoclonal antibody-based urine Histoplasma antigen enzyme immunoassay (IMMY) for the diagnosis of histoplasmosis in cats. J VET INTERN MED 2019;33:603-610.
• Wilson AG, et cl. Clinical signs, treatment, and prognostic factors for dogs with histoplasmosis. J AM VET MED ASSOC 2018;252:201-209.
• Ludwig HC, et al. Candidate prognostic indicators in cats with histoplasmosis treated with antifungal therapy. J FEL MED SURG;2018:985-996.
• Fielder SE, et al. Feline histoplasmosis presenting with bone and joint involvement: clinical and diagnostic findings in 25 cats. J FEL MED SURG 2018;20:1777-1179.
• Clark K, et al. Evaluation of a novel monoclonal antibody-based enzyme immunoassay for detection of Histoplasma antigen in urine of dogs. J VET INTERN MED 2020.

Antifungal Therapy:

• Renschler J, et al. Comparison of compounded, generic, and innovator-formulated itraconazole in dogs and cats. J AM ANIM HOSP ASSOC 2018;54:195-200.
• Mawby, DI, et al. Bioequivalence of orally administered generic, compounded, and innovator-formulated itraconazole in healthy dogs. J VET INTERN MED 2014;28:72-77.
• Mawby DI, et al. Comparison of absorption characteristics of oral reference and compounded itraconazole formulations in healthy cats. J AM VET MED ASSOC 2018;252:195-200.
• Middleton SM. Alternate-day dosing of itraconazole in healthy adult cats. J VET PHARMACOL THER 2016;39:27-31
• Foy DS, et al. Antifungal treatment of small animal veterinary patients. VET CLIN SM ANIM PRACT 2010;40:1171-1188
• Mazepa ASW, et al. Retrospective comparison of the efficacy of fluconazole or itraconazole for the treatment of systemic blastomycosis in dogs. J VET INTERN MED 2011;25:440-445.
• Mawby DI, et al. Posaconazole pharmacokinetics in healthy cats after oral and intravenous administration. J VET INTERN MED 2016;30:1703-1707.
  
• Kendall J et al. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs. AM J VET RES 2015;76:454-459.
• Vishkautsan P, et al. Pharmacokinetics of voriconazole after intravenous and oral administration to healthy cats. AM J VET RES 2016;77:931-939.
• Lemetayer JD, et al. Pharmacokinetics and distribution of voriconazole in body fluids of dogs after repeated oral dosing. VET PHARMACOL THERAP 2015;38:451-456.